<DOC>
	<DOCNO>NCT00646100</DOCNO>
	<brief_summary>Transcatheter arterial chemoembolization ( TACE ) prove improve survival middle stage hepatocellular carcinoma ( HCC ) , advanced stage HCC ' efficacy prove . The investigator hypothesize TACE also improve survival advance stage HCC . Thus , investigator carry prospective control study find survival patient TACE well best support .</brief_summary>
	<brief_title>Transarterial Chemoembolization Unresectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Thrombosis</mesh_term>
	<criteria>The diagnosis HCC base diagnostic criterion HCC use European Association Study Liver ( EASL ) Tumor size &gt; 7 cm portal vein invasion , tumor consider unresectable No previous HCC direct treatment Eastern Cooperative Group performance status 01 Liver function : Child 's A Avascular tumor Evidence hepatic decompensation include ascites , gastrointestinal bleeding hepatic encephalopathy underlie serve cardiac renal disease Known suspect allergy investigational agent agent give association trial Diffusetype HCC For patient main portal vein occlusion , adequate collateral circulation around occlude portal vein</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>hepatocellular carcinoma</keyword>
	<keyword>transcatheter arterial chemoembolization</keyword>
	<keyword>prospective control study</keyword>
	<keyword>best support care</keyword>
	<keyword>survival</keyword>
</DOC>